- An extensive, multi-national market research study on the HPV virus amongst 15,000 Europeans in 10 countries
- One in three respondents have never heard of HPV and only 3% who had heard of HPV were aware that most people will contract HPV in their lifetime
- Just over half of all respondents that were aware of HPV (51%) didn’t agree or didn’t know that HPV could cause cancer in males
- Research undertaken by Ipsos, the global market research firm, on behalf of MSD
A large-scale Ipsos market research study taking place in 10 European countries, demonstrated substantial knowledge and awareness differences around the human papillomavirus (HPV). 15,000 men and women in 10 European countries took part in this significant study conducted by global market research firm Ipsos, on behalf of MSD.
Nearly all cervical cancers (99.7%) are caused by infection with a high-risk type of HPV. It is the fourth-most frequent cancer in women and has a high mortality rate globally, according to the World Health Organisation (WHO). In addition, HPV infections are responsible for a range of non-cervical diseases in both men and women that have serious morbidity and contribute to a substantial healthcare burden.
Highlights from this comprehensive study included:
- Mixed awareness of HPV across Europe
- Misunderstanding about how common the HPV virus is
- Many respondents were not aware that men are at risk of contracting HPV and HPV-related cancers
Helen Cox, senior director, Ipsos Healthcare, added, “This market research is a comprehensive study into the awareness and perceptions of the human papillomavirus (HPV) including 15,000 adults (16-60 years) across 10 countries in Europe. This survey provides robust benchmarks of levels of awareness and knowledge of HPV across the 10 European countries and perhaps, more significantly, an understanding of how this differs between these countries”.
In addition to cervical cancer, HPV infections are responsible for a range of non-cervical diseases in both sexes that have serious morbidity and contribute to a substantial healthcare burden.
Technical Note: What is the Human Papilloma Virus (HPV)?
HPV is the name given to a common group of viruses; there are more than 100 types of HPV
Most people – regardless of gender – will have been exposed to HPV in their lifetime and for most people the virus goes away naturally.
In the vast majority of cases, there will be no symptoms and the infection will clear on its own, but in some cases persistent infection can lead to HPV-related cancers and diseases.
Some types of HPV are high risk because they are linked to the development of some cancers
Other lower risk HPV types can lead to genital warts
Nearly all cervical cancers (99.7%) are caused by infection from a high risk HPV
Source: NHS Choices (UK)
About the research
This study has been initiated and funded by MSD and is managed and owned by MSD. MSD has had full editorial control and approval of the research results. On behalf of MSD, Ipsos interviewed a representative quota sample of 15,000 adults across Europe (Austria 1,000, Belgium 1,000, France 2,000, Germany 2,000, Greece 1,000, Italy 2,000, Portugal 1,000, Spain 2,000, Switzerland 1,000 and UK 2,000) aged 16 to 60 years. Surveys were conducted online between 7th and 21st January 2019. The sample obtained is based on quotas in terms of gender, age, region and working status at a country level and survey data were subsequently weighted to the known population proportions of this audience.
Ipsos Healthcare Launches Syndicated Pan-Cancer Testing Monitor in Australia
Ipsos Healthcare has announced the expansion of its syndicated Pan-Cancer Testing Monitor (PCTM) to the Australian market. The PCTM, which has been running in the US since 2016, measures and tracks the usage of pan-cancer tests, which are designed to test for a wide range of cancer types to help doctors make more informed treatment decisions.